PH19156A - Dihydrocyclosporin d in the treatment of multiple sclerosis - Google Patents

Dihydrocyclosporin d in the treatment of multiple sclerosis

Info

Publication number
PH19156A
PH19156A PH28447A PH28447A PH19156A PH 19156 A PH19156 A PH 19156A PH 28447 A PH28447 A PH 28447A PH 28447 A PH28447 A PH 28447A PH 19156 A PH19156 A PH 19156A
Authority
PH
Philippines
Prior art keywords
dihydrocyclosporin
treatment
multiple sclerosis
sclerosis
Prior art date
Application number
PH28447A
Other languages
English (en)
Inventor
Salvatore Cammisuli
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH19156A publication Critical patent/PH19156A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH28447A 1982-02-01 1983-01-28 Dihydrocyclosporin d in the treatment of multiple sclerosis PH19156A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202776 1982-02-01

Publications (1)

Publication Number Publication Date
PH19156A true PH19156A (en) 1986-01-15

Family

ID=10528015

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28447A PH19156A (en) 1982-02-01 1983-01-28 Dihydrocyclosporin d in the treatment of multiple sclerosis

Country Status (5)

Country Link
JP (1) JPS58134031A (fr)
AU (1) AU558155B2 (fr)
BE (1) BE895724A (fr)
IT (1) IT1197556B (fr)
PH (1) PH19156A (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
EP0365044A3 (fr) * 1984-08-02 1990-08-22 Sandoz Ag Utilisation pharmaceutique de (NVA)2-cyclosporine
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US7081445B2 (en) * 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (da) * 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4329503A1 (de) * 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
US6204243B1 (en) 1993-09-01 2001-03-20 Novatis Ag Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
JP3833248B2 (ja) 1994-11-03 2006-10-11 ノバルティス・アクチエンゲゼルシャフト 簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
AU737053B2 (en) 1997-01-30 2001-08-09 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
IN188719B (fr) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
WO2009042892A1 (fr) * 2007-09-26 2009-04-02 Oregon Health & Science University Undécapeptides cycliques et leurs dérivés comme thérapies pour la sclérose en plaques

Also Published As

Publication number Publication date
IT8347644A0 (it) 1983-02-01
IT1197556B (it) 1988-12-06
AU558155B2 (en) 1987-01-22
BE895724A (fr) 1983-07-28
JPS58134031A (ja) 1983-08-10
AU1085183A (en) 1983-08-11

Similar Documents

Publication Publication Date Title
GB2122498B (en) Massager
DE3377263D1 (en) Skin treatment composition
PH19156A (en) Dihydrocyclosporin d in the treatment of multiple sclerosis
DE3378116D1 (en) Phenyl alpha-acyloxyacetamide derivates and their therapeutic use
GB8333890D0 (en) Metal treatment
JPS57171767A (en) Sizining treatment
GB2114021B (en) Baths
CA49536S (en) Bathtub
EG16991A (en) Therapeutic agents
GB2127261B (en) A process of sea-ranching salmon and the like
ZA837697B (en) Improvements in or relating to the treatment of multi-phase systems
GB2128192B (en) Naphthalenecarboxamides their production and use
ZA83662B (en) Skin treatment composition
GB8318580D0 (en) Therapeutic agent
GB2147008B (en) Surface treatment
ZA836848B (en) Therapeutic agents
GB2077265B (en) N-trifluoroacetyladriamycin-14-o-hemiglutarate and hemiadipate and therapeutic compositions containing the same
DE3367919D1 (en) Furochromones and furobenzopyrans
GB2368215B (en) Ranging
PT76807B (en) Phosphoramidothionate and their production and use
CA49742S (en) Treatment chair
ZA834855B (en) Treatment
ZW21283A1 (en) The treatment of ferromanganese
ZA837183B (en) The treatment of ferromanganese
GB8315399D0 (en) Treatment